1kb4 › Citations

Structural basis of VDR-DNA interactions on direct repeat response elements.

Shaffer PL, Gewirth DT
EMBO J 21 2242-52 (2002)
Related entries: 1kb2, 1kb6

Cited: 70 times
EuropePMC logo PMID: 11980721

Abstract

The vitamin D receptor (VDR) forms homo- or heterodimers on response elements composed of two hexameric half-sites separated by 3 bp of spacer DNA. We describe here the crystal structures at 2.7-2.8 A resolution of the VDR DNA-binding region (DBD) in complex with response elements from three different promoters: osteopontin (SPP), canonical DR3 and osteocalcin (OC). These structures reveal the chemical basis for the increased affinity of VDR for the SPP response element, and for the poor stability of the VDR-OC complex, relative to the canonical DR3 response element. The homodimeric protein-protein interface is stabilized by van der Waals interactions and is predominantly non-polar. An extensive alpha-helix at the C-terminal end of the VDR DBD resembles that found in the thyroid hormone receptor (TR), and suggests a mechanism by which VDR and TR discriminate among response elements. Selective structure-based mutations in the asymmetric homodimeric interface result in a VDR DBD protein that is defective in homodimerization but now forms heterodimers with the 9-cis retinoic acid receptor (RXR) DBD.

Reviews - 1kb4 mentioned but not cited (2)

  1. The nuclear receptor superfamily: A structural perspective. Weikum ER, Liu X, Ortlund EA. Protein Sci 27 1876-1892 (2018)
  2. Vitamin D and Its Receptor from a Structural Perspective. Rochel N. Nutrients 14 2847 (2022)

Articles - 1kb4 mentioned but not cited (7)

  1. Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA. Orlov I, Rochel N, Moras D, Klaholz BP. EMBO J 31 291-300 (2012)
  2. Structural basis of VDR-DNA interactions on direct repeat response elements. Shaffer PL, Gewirth DT. EMBO J 21 2242-2252 (2002)
  3. Novel DNA-binding element within the C-terminal extension of the nuclear receptor DNA-binding domain. Jakób M, Kołodziejczyk R, Orłowski M, Krzywda S, Kowalska A, Dutko-Gwóźdź J, Gwóźdź T, Kochman M, Jaskólski M, Ozyhar A. Nucleic Acids Res 35 2705-2718 (2007)
  4. DNA-binding residues and binding mode prediction with binding-mechanism concerned models. Huang YF, Huang CC, Liu YC, Oyang YJ, Huang CK. BMC Genomics 10 Suppl 3 S23 (2009)
  5. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
  6. A multidisciplinary approach disclosing unexplored Aflatoxin B1 roles in severe impairment of vitamin D mechanisms of action. Persico M, Sessa R, Cesaro E, Dini I, Costanzo P, Ritieni A, Fattorusso C, Grosso M. Cell Biol Toxicol 39 1275-1295 (2023)
  7. Residue correlation networks in nuclear receptors reflect functional specialization and the formation of the nematode-specific P-box. Afonso MQ, de Lima LH, Bleicher L. BMC Genomics 14 Suppl 6 S1 (2013)


Reviews citing this publication (21)

  1. Vitamin D. Dusso AS, Brown AJ, Slatopolsky E. Am J Physiol Renal Physiol 289 F8-28 (2005)
  2. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Physiol Rev 96 365-408 (2016)
  3. Overview of nomenclature of nuclear receptors. Germain P, Staels B, Dacquet C, Spedding M, Laudet V. Pharmacol Rev 58 685-704 (2006)
  4. Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. di Masi A, De Marinis E, Ascenzi P, Marino M. Mol Aspects Med 30 297-343 (2009)
  5. Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Claessens F, Denayer S, Van Tilborgh N, Kerkhofs S, Helsen C, Haelens A. Nucl Recept Signal 6 e008 (2008)
  6. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment. Tebben PJ, Singh RJ, Kumar R. Endocr Rev 37 521-547 (2016)
  7. Looking at nuclear receptors from a new angle. Helsen C, Claessens F. Mol Cell Endocrinol 382 97-106 (2014)
  8. Vitamin D and the brain: Genomic and non-genomic actions. Cui X, Gooch H, Petty A, McGrath JJ, Eyles D. Mol Cell Endocrinol 453 131-143 (2017)
  9. Understanding nuclear receptor form and function using structural biology. Rastinejad F, Huang P, Chandra V, Khorasanizadeh S. J Mol Endocrinol 51 T1-T21 (2013)
  10. New aspects of vitamin D metabolism and action - addressing the skin as source and target. Bikle D, Christakos S. Nat Rev Endocrinol 16 234-252 (2020)
  11. Genome-wide (over)view on the actions of vitamin D. Carlberg C. Front Physiol 5 167 (2014)
  12. Structural and functional analysis of domains of the progesterone receptor. Hill KK, Roemer SC, Churchill ME, Edwards DP. Mol Cell Endocrinol 348 418-429 (2012)
  13. A current structural perspective on PXR and CAR in drug metabolism. Buchman CD, Chai SC, Chen T. Expert Opin Drug Metab Toxicol 14 635-647 (2018)
  14. Vitamin D-Induced Molecular Mechanisms to Potentiate Cancer Therapy and to Reverse Drug-Resistance in Cancer Cells. Negri M, Gentile A, de Angelis C, Montò T, Patalano R, Colao A, Pivonello R, Pivonello C. Nutrients 12 E1798 (2020)
  15. Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view. Carlberg C, Molnár F. Can J Physiol Pharmacol 93 311-318 (2015)
  16. Structural considerations of vitamin D signaling. Molnár F. Front Physiol 5 191 (2014)
  17. Convergence of lipid homeostasis through liver X and thyroid hormone receptors. Berkenstam A, Färnegårdh M, Gustafsson JA. Mech Ageing Dev 125 707-717 (2004)
  18. Activation of PPARδ: from computer modelling to biological effects. Kahremany S, Livne A, Gruzman A, Senderowitz H, Sasson S. Br J Pharmacol 172 754-770 (2015)
  19. Structural aspects of Vitamin D endocrinology. Rochel N, Molnár F. Mol Cell Endocrinol 453 22-35 (2017)
  20. Relationship of structure and function of DNA-binding domain in vitamin D receptor. Wan LY, Zhang YQ, Chen MD, Liu CB, Wu JF. Molecules 20 12389-12399 (2015)
  21. Vitamin D3 and Ischemic Stroke: A Narrative Review. Lasoń W, Jantas D, Leśkiewicz M, Regulska M, Basta-Kaim A. Antioxidants (Basel) 11 2120 (2022)

Articles citing this publication (40)

  1. Preformed structural elements feature in partner recognition by intrinsically unstructured proteins. Fuxreiter M, Simon I, Friedrich P, Tompa P. J Mol Biol 338 1015-1026 (2004)
  2. Structural basis of androgen receptor binding to selective androgen response elements. Shaffer PL, Jivan A, Dollins DE, Claessens F, Gewirth DT. Proc Natl Acad Sci U S A 101 4758-4763 (2004)
  3. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. Zhou C, Assem M, Tay JC, Watkins PB, Blumberg B, Schuetz EG, Thummel KE. J Clin Invest 116 1703-1712 (2006)
  4. Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings. Rochel N, Ciesielski F, Godet J, Moman E, Roessle M, Peluso-Iltis C, Moulin M, Haertlein M, Callow P, Mély Y, Svergun DI, Moras D. Nat Struct Mol Biol 18 564-570 (2011)
  5. Vitamin D Switches BAF Complexes to Protect β Cells. Wei Z, Yoshihara E, He N, Hah N, Fan W, Pinto AFM, Huddy T, Wang Y, Ross B, Estepa G, Dai Y, Ding N, Sherman MH, Fang S, Zhao X, Liddle C, Atkins AR, Yu RT, Downes M, Evans RM. Cell 173 1135-1149.e15 (2018)
  6. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3. Väisänen S, Dunlop TW, Sinkkonen L, Frank C, Carlberg C. J Mol Biol 350 65-77 (2005)
  7. The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene. Saavalainen K, Pasonen-Seppänen S, Dunlop TW, Tammi R, Tammi MI, Carlberg C. J Biol Chem 280 14636-14644 (2005)
  8. Monomeric complex of human orphan estrogen related receptor-2 with DNA: a pseudo-dimer interface mediates extended half-site recognition. Gearhart MD, Holmbeck SM, Evans RM, Dyson HJ, Wright PE. J Mol Biol 327 819-832 (2003)
  9. Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer. Yasmin R, Williams RM, Xu M, Noy N. J Biol Chem 280 40152-40160 (2005)
  10. Structure of the heterodimeric ecdysone receptor DNA-binding complex. Devarakonda S, Harp JM, Kim Y, Ozyhar A, Rastinejad F. EMBO J 22 5827-5840 (2003)
  11. Research Support, Non-U.S. Gov't The vitamin D slant on allergy. Wjst M. Pediatr Allergy Immunol 17 477-483 (2006)
  12. Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements. Roemer SC, Donham DC, Sherman L, Pon VH, Edwards DP, Churchill ME. Mol Endocrinol 20 3042-3052 (2006)
  13. Extent of structural asymmetry in homodimeric proteins: prevalence and relevance. Swapna LS, Srikeerthana K, Srinivasan N. PLoS One 7 e36688 (2012)
  14. Integration of the activation of the human hyaluronan synthase 2 gene promoter by common cofactors of the transcription factors retinoic acid receptor and nuclear factor kappaB. Saavalainen K, Tammi MI, Bowen T, Schmitz ML, Carlberg C. J Biol Chem 282 11530-11539 (2007)
  15. The role of the C-terminal extension (CTE) of the estrogen receptor alpha and beta DNA binding domain in DNA binding and interaction with HMGB. Melvin VS, Harrell C, Adelman JS, Kraus WL, Churchill M, Edwards DP. J Biol Chem 279 14763-14771 (2004)
  16. Predicting specificity-determining residues in two large eukaryotic transcription factor families. Donald JE, Shakhnovich EI. Nucleic Acids Res 33 4455-4465 (2005)
  17. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity. Solomon IH, Hager JM, Safi R, McDonnell DP, Redinbo MR, Ortlund EA. J Mol Biol 354 1091-1102 (2005)
  18. A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain. Hill KK, Roemer SC, Jones DN, Churchill ME, Edwards DP. J Biol Chem 284 24415-24424 (2009)
  19. Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding. Roemer SC, Adelman J, Churchill ME, Edwards DP. Nucleic Acids Res 36 3655-3666 (2008)
  20. Structural analysis of RXR-VDR interactions on DR3 DNA. Shaffer PL, Gewirth DT. J Steroid Biochem Mol Biol 89-90 215-219 (2004)
  21. Structural basis of natural promoter recognition by a unique nuclear receptor, HNF4alpha. Diabetes gene product. Lu P, Rha GB, Melikishvili M, Wu G, Adkins BC, Fried MG, Chi YI. J Biol Chem 283 33685-33697 (2008)
  22. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease. Zhang H, Shen Z, Lin Y, Zhang J, Zhang Y, Liu P, Zeng H, Yu M, Chen X, Ning L, Mao X, Cen L, Yu C, Xu C. J Biol Chem 295 3891-3905 (2020)
  23. H2O2-dependent translocation of TCTP into the nucleus enables its interaction with VDR in human keratinocytes: TCTP as a further module in calcitriol signalling. Rid R, Onder K, Trost A, Bauer J, Hintner H, Ritter M, Jakab M, Costa I, Reischl W, Richter K, MacDonald S, Jendrach M, Bereiter-Hahn J, Breitenbach M. J Steroid Biochem Mol Biol 118 29-40 (2010)
  24. Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis. Rosen MD, Privalsky ML. J Thyroid Res 2011 361304 (2011)
  25. Structure of a thyroid hormone receptor DNA-binding domain homodimer bound to an inverted palindrome DNA response element. Chen Y, Young MA. Mol Endocrinol 24 1650-1664 (2010)
  26. Ligand-mediated conformational changes of the VDR are required for gene transactivation. Carlberg C. J Steroid Biochem Mol Biol 89-90 227-232 (2004)
  27. The replication initiator of the cholera pathogen's second chromosome shows structural similarity to plasmid initiators. Orlova N, Gerding M, Ivashkiv O, Olinares PDB, Chait BT, Waldor MK, Jeruzalmi D. Nucleic Acids Res 45 3724-3737 (2017)
  28. HDX reveals the conformational dynamics of DNA sequence specific VDR co-activator interactions. Zheng J, Chang MR, Stites RE, Wang Y, Bruning JB, Pascal BD, Novick SJ, Garcia-Ordonez RD, Stayrook KR, Chalmers MJ, Dodge JA, Griffin PR. Nat Commun 8 923 (2017)
  29. Molecular determinants of MED1 interaction with the DNA bound VDR-RXR heterodimer. Belorusova AY, Bourguet M, Hessmann S, Chalhoub S, Kieffer B, Cianférani S, Rochel N. Nucleic Acids Res 48 11199-11213 (2020)
  30. Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements. Jiang L, Dai S, Li J, Liang X, Qu L, Chen X, Guo M, Chen Z, Chen L, Wei H, Chen Y. J Biol Chem 294 19795-19803 (2019)
  31. Vitamin D Receptor Mediates a Myriad of Biological Actions Dependent on Its 1,25-Dihydroxyvitamin D Ligand: Distinct Regulatory Themes Revealed by Induction of Klotho and Fibroblast Growth Factor-23. Haussler MR, Livingston S, Sabir ZL, Haussler CA, Jurutka PW. JBMR Plus 5 e10432 (2021)
  32. Research Support, U.S. Gov't, Non-P.H.S. Vitamin D and lung cancer. Ramnath N, Kim S, Christensen PJ. Expert Rev Respir Med 5 305-309 (2011)
  33. A functional common polymorphism in the vitamin D-responsive element of the GH1 promoter contributes to isolated growth hormone deficiency. Giordano M, Godi M, Mellone S, Petri A, Vivenza D, Tiradani L, Carlomagno Y, Ferrante D, Arrigo T, Corneli G, Bellone S, Giacopelli F, Santoro C, Bona G, Momigliano-Richiardi P. J Clin Endocrinol Metab 93 1005-1012 (2008)
  34. Deciphering the calcitriol-induced transcriptomic response in keratinocytes: presentation of novel target genes. Rid R, Wagner M, Maier CJ, Hundsberger H, Hintner H, Bauer JW, Onder K. J Mol Endocrinol 50 131-149 (2013)
  35. Cell-Type Specific Determinants of NRAMP1 Expression in Professional Phagocytes. Cellier MF. Biology (Basel) 2 233-283 (2013)
  36. Genes Regulated by Vitamin D in Bone Cells Are Positively Selected in East Asians. Arciero E, Biagini SA, Chen Y, Xue Y, Luiselli D, Tyler-Smith C, Pagani L, Ayub Q. PLoS One 10 e0146072 (2015)
  37. Impaired Vitamin D Signaling in T Cells From a Family With Hereditary Vitamin D Resistant Rickets. Al-Jaberi FAH, Kongsbak-Wismann M, Aguayo-Orozco A, Krogh N, Buus TB, Lopez DV, Rode AKO, Gravesen E, Olgaard K, Brunak S, Woetmann A, Ødum N, Bonefeld CM, Geisler C. Front Immunol 12 684015 (2021)
  38. Efficient stable isotope labeling and purification of vitamin D receptor from inclusion bodies. Zhu J, Rao H, Tonelli M, Westler WM, Singarapu KK, Markley JL, DeLuca HF, Assadi-Porter FM. Protein Expr Purif 85 25-31 (2012)
  39. Structural overview and perspectives of the nuclear receptors, a major family as the direct targets for small-molecule drugs. Li F, Song C, Zhang Y, Wu D. Acta Biochim Biophys Sin (Shanghai) 54 12-24 (2022)
  40. Structures of human TR4LBD-JAZF1 and TR4DBD-DNA complexes reveal the molecular basis of transcriptional regulation. Liu Y, Ma L, Li M, Tian Z, Yang M, Wu X, Wang X, Shang G, Xie M, Chen Y, Liu X, Jiang L, Wu W, Xu C, Xia L, Li G, Dai S, Chen Z. Nucleic Acids Res 51 1443-1457 (2023)


Quick links